ESR1 and breast neoplasm: Discordance between ERα expression and assessment of molecular subtype by RNA-based methods has also been observed in human breast tumours, with between 1 and 3% of ERα-positive tumours displaying a basal-like phenotype (Perou et al., 2000; Sørlie et al., 2001; Sorlie et al., 2003).